M.B. PHARMOS A/S (CVR 18776405) company profile

Ownership

No current owner is registered.

Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.

Former owners (1)

ORDRUPHØJ INVEST I ApS
CVR 83099518100% of capital and votes30 Nov 2006 to 6 Dec 2019

Dandex estimates

Auditor's report (revisorpåtegning): Not determinedNot decided yet: Dandex has not read this company's annual reports for it. Dandex estimate, rules and decision model v1, computed 14 Nov 2026.
Auditor's report findings (revisorpåtegning): Pro: Auditor's report findings (revisorpåtegning) is in the Pro plan, see pricingThe auditor's findings: conclusion, going concern, emphasis, other matters, breaches.
Business model (forretningsmodel): Not determinedNot decided yet: Dandex has not read this company's annual reports for it. Dandex estimate, rules and decision model v1, computed 14 Nov 2026.
Revenue model (indtægtsmodel): Pro: Revenue model (indtægtsmodel) is in the Pro plan, see pricingThe kinds of revenue the accounting policies name, and the main one.

Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report, the business model and the revenue model a calibrated decision model reading the report's text and the purpose clause, not registered by the company. Each label links to its definition.

People

Current (0)

CVR lists no current officers for this company.

Founders (1)

VX 10.312 ApSFounded 1 Sep 1995

CVR records founders at incorporation. It does not record whether they are alive or still involved.

Former (18)

Hans Ole SvendsenExecutive board 11 Jan 1999 to 13 Sep 2002, Board of directors 18 Dec 1995 to 1 Jul 2002
Annette Helene SchachtExecutive board 1 Jul 2002 to 13 Sep 2002
Laurits Henning LauritsenExecutive board 8 Apr 2014 to 15 Jun 2017, Board of directors 8 Apr 2014 to 3 Jun 2017
Birgitte Ulrich HøyerExecutive board 13 Sep 2002 to 6 Dec 2019, Board of directors 6 Oct 2003 to 6 Dec 2019
Jesper Breuning-HansenExecutive board 11 Jan 1999 to 11 Jan 1999, Board of directors 29 Dec 2000 to 8 Apr 2014
Per Emil Hasselbalch StakemannExecutive board 1 Sep 1995 to 18 Dec 1995
Johannes Fausbøll MosbechExecutive board 18 Dec 1995 to 11 Jan 1999, Board of directors 13 Sep 2002 to 24 Apr 2013
Christian Frederik HøyerBoard of directors 13 Sep 2002 to 6 Oct 2003
Susanne LauritsenBoard of directors 8 Apr 2014 to 6 Dec 2019
Holger Fausbøll MosbechBoard of directors 11 Jan 1999 to 8 Dec 2003
Jonas Hammershaimb MosbechBoard of directors 5 Mar 2012 to 15 Jun 2017
Pernille Ulrich BerthelsenBoard of directors 8 Apr 2014 to 6 Dec 2019
Hans Henrik RaithBoard of directors 29 Dec 2000 to 13 Sep 2002
Margrethe MosbechBoard of directors 18 Dec 1995 to 15 Feb 1997
Anette Breuning-HansenBoard of directors 18 Dec 1995 to 15 Feb 1997
Juhani PaloluomaBoard of directors 15 Feb 1997 to 29 Dec 2000
Hans Helge Steffensen SkelhøjAuditor 13 Sep 2002 to 14 Mar 2007
Erik Tronborg AndersenAuditor 1 Sep 1995 to 18 Dec 1995

Roles over time

Former (18)

Birgitte Ulrich Høyer: Executive board, 13 Sep 2002 to 6 Dec 2019; Board of directors, 6 Oct 2003 to 6 Dec 2019.
Susanne Lauritsen: Board of directors, 8 Apr 2014 to 6 Dec 2019.
Pernille Ulrich Berthelsen: Board of directors, 8 Apr 2014 to 6 Dec 2019.
Laurits Henning Lauritsen: Executive board, 8 Apr 2014 to 15 Jun 2017; Board of directors, 8 Apr 2014 to 3 Jun 2017.
Jonas Hammershaimb Mosbech: Board of directors, 5 Mar 2012 to 15 Jun 2017.
Jesper Breuning-Hansen: Executive board, 11 Jan 1999 to 11 Jan 1999; Board of directors, 29 Dec 2000 to 8 Apr 2014.
Johannes Fausbøll Mosbech: Executive board, 18 Dec 1995 to 11 Jan 1999; Board of directors, 13 Sep 2002 to 24 Apr 2013.
Hans Helge Steffensen Skelhøj: Auditor, 13 Sep 2002 to 14 Mar 2007.
Holger Fausbøll Mosbech: Board of directors, 11 Jan 1999 to 8 Dec 2003.
Christian Frederik Høyer: Board of directors, 13 Sep 2002 to 6 Oct 2003.
Hans Ole Svendsen: Board of directors, 18 Dec 1995 to 1 Jul 2002; Executive board, 11 Jan 1999 to 13 Sep 2002.
Annette Helene Schacht: Executive board, 1 Jul 2002 to 13 Sep 2002.
Hans Henrik Raith: Board of directors, 29 Dec 2000 to 13 Sep 2002.
Juhani Paloluoma: Board of directors, 15 Feb 1997 to 29 Dec 2000.
Margrethe Mosbech: Board of directors, 18 Dec 1995 to 15 Feb 1997.
Anette Breuning-Hansen: Board of directors, 18 Dec 1995 to 15 Feb 1997.
Per Emil Hasselbalch Stakemann: Executive board, 1 Sep 1995 to 18 Dec 1995.
Erik Tronborg Andersen: Auditor, 1 Sep 1995 to 18 Dec 1995.

1 Sep 1995 to 14 Nov 2026.

Executive board (direktion)Board of directors (bestyrelse)Other rolesEach bar is one role, from its start to its end or today. Bars in a group share one scale. Source: CVR.

Network

Headcount

EmployeesFTE

Q3 2019, quarterly: 0 employees, 1 FTE

Show as table

Registry headcount, 1997 to Q3 2019, oldest left to newest right
Period	1997	1998	1999	2000	2001	2002	2004	2005	2006	2007	2012	2014	Sep 2016	Oct 2016	Oct 2017	Apr 2019	Q3 2019
Employees	3	4	2	3	4	1	1	1	2	1	0	0	1	3	2	3	0
FTE	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	2	1
Series	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Annual	Monthly	Monthly	Monthly	Monthly	Quarterly

The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Annual 1997 to 2014; quarterly Q3 2019; monthly Sep 2016 to Apr 2019.

Latest Q3 2019, published 2 Jan 2020. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).

Financials

Annual report figures by year, DKK thousands
Metric	2014	2015	2016	2017	2018
Gross profit	Not reported	Not reported	Not reported	0	-1
Operating profit	+26	-21	-25	0	-1
Result for the year	+31	+34	+25	+33	+44
Equity	1,818	1,853	1,877	1,910	1,954
Total assets	1,829	1,878	1,898	1,912	1,954
Employees (average)	Not reported	Not reported	Not reported	Not reported	0
Credit metrics (Dandex calculations)
EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit.	Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit.
Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash.	Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash.
Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes.	Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes.
Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest.	Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest.
Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis.	Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis.
ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt.	Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt.
Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue.	Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue.
FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA.	Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA.

DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.

Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.

Credit rating (kreditvurdering): Pro: Credit rating (kreditvurdering) is in the Pro plan, see pricingA score from 0 to 100 with a grade from A to F, from the latest annual reports.
Capital loss (kapitaltab): Pro: Capital loss (kapitaltab) is in the Pro plan, see pricingNegative equity, or equity below half the share capital, in the latest report.
Filing deadline and punctuality (indsendelsesfrist): Pro: Filing deadline and punctuality (indsendelsesfrist) is in the Pro plan, see pricingThe next annual report deadline.

Annual reports

Annual report 2018
1 Jan 2018 to 31 Dec 2018, published 29 May 2019
PDF XHTML
Annual report 2017
1 Jan 2017 to 31 Dec 2017, published 30 May 2018
PDF XHTML
Annual report 2016
1 Jan 2016 to 31 Dec 2016, published 24 May 2017
PDF XHTML
Annual report 2015
1 Jan 2015 to 31 Dec 2015, published 27 Jan 2016
PDF XHTML
Annual report 2014
1 Jan 2014 to 31 Dec 2014, published 3 Jun 2015
PDF XHTML

Financials

Changes

No changes since Dandex began following this company. For announcements from before then, see Registrations.

Signals (signaler)

Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.

New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).

Changes

Pro for this company

The rows marked Pro on this page hold values in the Pro plan. For M.B. PHARMOS A/S, that is:

Credit and debt: Net interest-bearing debt, gearing, NIBD / EBITDA, interest coverage and adjusted equity ratio, for 2014 to 2018.Credit rating, capital loss and filing deadline and punctuality.
Returns and cash flow: EBITDA / gross profit, ROIC, capex % of sales and FCFF / EBITDA, for 2014 to 2018.
Advanced estimates: Auditor's report findings and revenue model.
Signals and monitoring: Signals on this company, as Dandex raises them.

See the Pro plan

Have Pro? Sign in to see the values on this page.

Registry facts

Signing rule (tegningsregel): Selskabet tegnes af direktøren eller 2 bestyrelsesmedlemmer i forening24 Apr 2013 to 6 Dec 2019
Purpose (formål): Selskabets formål er at udvikle, forædle, sælge og handle med produkter indenfor lægemiddelindustrien samt udøve hermed beslægtet virksomhed af enhver art.24 Apr 2013 to 6 Dec 2019
Audit opted out (revision fravalgt): Yes1 Sep 1995 to 6 Dec 2019
Articles of association last changed (seneste vedtægtsdato): 24 Apr 2013until 6 Dec 2019
Owners under 5% registered (ejerregistrering under 5 procent): No26 Oct 2016 to 6 Dec 2019

Share capital

Each registered value from the day it took effect, newest first.

13 Sep 2002DKK 1,500,000+1,000,000
3 Oct 2001DKK 500,000+300,000
11 Sep 1995DKK 200,000Earliest in CVR

Mergers and demergers

6 Dec 2019
Merger (fusion), as the ceasing company (ophørende selskab)
- ORDRUPHØJ INVEST I ApSCVR 83099518, continuing company, active

From CVR, read 14 Nov 2026. Text such as the signing rule and purpose is shown as registered.

Registry facts

History (historik)

Name changes: 2 in all, none in the last 5 years; latest 3 Oct 2001
Address changes: 4 in all, none in the last 5 years; latest 15 Jun 2010
Status changes: 1 in all, none in the last 5 years; latest 6 Dec 2019
Auditor changes: 1 in all, none in the last 5 years; latest 14 Mar 2007

Names (navne)

3 Oct 2001 to 6 Dec 2019
M.B. PHARMOS A/S
5 Jan 1996 to 2 Oct 2001
M.B. PHARMOS ApS
1 Sep 1995 to 4 Jan 1996
ApS KBUS 8 NR. 4186

Addresses (adresser)

15 Jun 2010 to 6 Dec 2019
Ryvangs Allé 18, 2100 København Ø
15 Nov 2002 to 14 Jun 2010
Store Kongensgade 68, st. tv, 1264 København K
13 Sep 2002 to 14 Nov 2002
Store Kongensgade 68, 1264 København K
3 Oct 2001 to 12 Sep 2002
Hammervej 7, 2970 Hørsholm
1 Sep 1995 to 2 Oct 2001
Høje Skodsborgvej 24, 2942 Skodsborg

Statuses (virksomhedsstatus)

6 Dec 2019 to 6 Dec 2019
Dissolved after merger (opløst efter fusion)
1 Sep 1995 to 5 Dec 2019
Active (normal)

Audit firms (revision)

14 Mar 2007 to 24 Apr 2013
CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB
1 Sep 1995 to 13 Sep 2002
CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB

From CVR, read 14 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.

History (historik)

Registrations (registreringer)

23 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.

5 Feb 2020
Merger or demerger completed
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion.
Virksomheden er d. 06.12.2019 opløst ved fusion med CVR-nummer: 83099518 ORDRUPHØJ INVEST I ApS.
12 Oct 2019
People change
Bestyrelse:
Fratrådte:
Laurits Henning Lauritsen, den 03.06.2017.
7 Oct 2019
Merger or demerger announced
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 83099518 ORDRUPHØJ INVEST I ApS (fortsættende) og CVR-nummer: 18776405 M.B. PHARMOS A/S (ophørende).
Kapitalejerne i CVR-nummer: 83099518 ORDRUPHØJ INVEST I ApS og CVR-nummer: 18776405 M.B. PHARMOS A/S har i enighed besluttet, at der ikke skal udarbejdes en erklæring om kreditorernes stilling i forbindelse med fusionen. Kreditorer, hvis fordringer er stiftet forud for bekendtgørelsen om fusionen, og for hvilke der ikke er stillet særskilt sikkerhed, kan anmelde deres fordringer senest 4 uger efter denne offentliggørelse.
21 Jun 2017
People change
Bestyrelse:
Fratrådte:
Jonas Hammershaimb Mosbech, den 15.06.2017.
Direktion:
Fratrådte:
Laurits Henning Lauritsen (adm. dir), den 15.06.2017.
7 Jan 2015
People change Other
Bestyrelse:
Udtrådt af bestyrelsen:
Jesper Breuning-Hansen, den 08.04.2014.
Indtrådt i bestyrelsen:
Pernille Ulrich Berthelsen, den 08.04.2014, Direktør Susanne Lauritsen, den 08.04.2014, Laurits Henning Lauritsen, den 08.04.2014.
Direktion:
Indtrådt i direktionen:
Laurits Henning Lauritsen (adm. dir), den 08.04.2014.
8 May 2013
Other Audit change People change
Vedtægter ændret:
24.04.2013.
Bestyrelse:
Udtrådt af bestyrelsen:
Johannes Fausbøll Mosbech, den 24.04.2013.
Selskabet tegnes af direktøren eller 2 bestyrelsesmedlemmer i forening.
Show the full announcement
Revision:
Udtrådt af revisionen:
CVR-NR. 15915641 CHRISTENSEN KJÆRULFF, STATSAUTORISERET REVISIONSAKTIESELSKAB, den 24.04.2013.
11 May 2012
People change Other
Bestyrelse:
Indtrådt i bestyrelsen:
Jonas Hammershaimb Mosbech, den 05.03.2012.
15 Jun 2010
Other
Ny adresse:
Ryvangs Allé 18, 2100 København Ø.
15 Mar 2007
Other Audit change
Revision:
Udtrådt af revisionen:
Hans Helge Steffensen Skelhøj, den 14.03.2007.
Indtrådt i revisionen:
CVR-NR. 15915641 S.A. CHRISTENSEN & W. KJÆRULFF, STATSAUTORISERET REVISIONSAKTIESELSKAB, Store Kongensgade 68, postboks 9015, 1264 København K, den 14.03.2007.
12 Dec 2003
Other People change
Bestyrelse:
Udtrådt af bestyrelsen:
Holger Fausbøll Mosbech, den 08.12.2003.

Show 13 more

24 Oct 2003
People change Other
Bestyrelse:
Udtrådt af bestyrelsen:
Christian Frederik Høyer, den 06.10.2003.
24 Oct 2003
People change Other
Bestyrelse:
Indtrådt i bestyrelsen:
Birgitte Ulrich Høyer, den 06.10.2003.
15 Nov 2002
Address change
Ny adresse:
Store Kongensgade 68, st. tv., 1264 København K.
22 Oct 2002
Audit change Address change Other Capital change People change
Vedtægter ændret:
13.09.2002.
Ny adresse:
c/o Palæ Administration, Store Kongensgade 68, 1264 København K.
Ny kommune:
København.
Show the full announcement
Kapitalforhøjelse:
kr. 1.000.000,00 indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 1.500.000,00.
Bestyrelse:
Tiltrådt som formand:
Johannes Fausbøll Mosbech, den 13.09.2002.
Udtrådt af bestyrelsen:
Hans Henrik Raith, den 13.09.2002.
Indtrådt i bestyrelsen:
Direktør Christian Frederik Høyer, den 13.09.2002.
Direktion:
Udtrådt af direktionen:
Annette Helene Schacht, den 13.09.2002, Hans Ole Svendsen, den 13.09.2002.
Indtrådt i direktionen:
Birgitte Ulrich Høyer, den 13.09.2002.
Selskabet tegnes af den samlede bestyrelse.
Revision:
Udtrådt af revisionen:
CVR-NR. 15915641 S.A. CHRISTENSEN & W. KJÆRULFF, STATSAUTORISERET REVISIONSAKTIESELSKAB, den 13.09.2002.
Indtrådt i revisionen:
Statsaut.revisor Hans Helge Skelhøj, 1264 København K, den 13.09.2002.
16 Aug 2002
Other People change
Bestyrelse:
Udtrådt af bestyrelsen:
Hans Ole Svendsen, den 01.07.2002.
Direktion:
Indtrådt i direktionen:
Annette Helene Schacht (adm. dir), den 01.07.2002.
21 Dec 2001
Conversion Capital change Address change Other
Vedtægter ændret:
03.10.2001.
Kapitalforhøjelse kr. 300.000,00: kr. 42.857,00 indbetalt kontant, kurs 2.120,00, kr. 257.143,00 indbetalt ved overførte reserver / overskud, kurs 100,00.
Selskabet er omdannet til et A/S med CVR-nr 18776405.
NAVN: M.B. PHARMOS A/S.
ADRESSE: Hammervej 7, 2970 Hørsholm.
Show the full announcement
Kommune:
Hørsholm.
Kapital kr. 500.000,00.
Bestyrelse:
Direktør Hans Henrik Raith (formand), Konsulent Jesper Breuning-Hansen, Dr. med Johannes Fausbøll Mosbech, Overlæge Holger Fausbøll Mosbech, Hans Ole Svendsen.
Direktion:
Hans Ole Svendsen.
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem, eller af den samlede bestyrelse.
Revision:
CVR-NR. 15915641 S.A. CHRISTENSEN & W. KJÆRULFF, STATSAUTORISERET REVISIONSAKTIESELSKAB, St. Kongensgade 68, postboks 9015, 1264 København K.
Regnskabsår:
01.01 - 31.12.
21 Mar 2001
Other People change
Bestyrelse:
Fratrådt som formand, men forbliver i bestyrelsen: Jesper Breuning-Hansen, den 29.12.2000.
Udtrådt af bestyrelsen:
Juhani Paloluoma, den 29.12.2000.
Indtrådt i bestyrelsen:
Direktør Hans Henrik Raith (formand), den 29.12.2000.
21 Apr 1999
Other People change
Bestyrelse:
Tiltrådt som formand:
Jesper Breuning-Hansen, den 11.01.1999.
Indtrådt i bestyrelsen:
Overlæge Holger Fausbøll Mosbech, den 11.01.1999.
Direktion:
Show the full announcement
Udtrådt af direktionen:
Jesper Breuning-Hansen, den 11.01.1999, den 11.01.1999, Johannes Fausbøll Mosbech, den 11.01.1999.
Indtrådt i direktionen:
Hans Ole Svendsen, den 11.01.1999.
18 Jul 1997
Other People change
Vedtægter ændret:
15.02.1997.
Bestyrelse:
Udtrådt af bestyrelsen:
Anette Breuning-Hansen, den 15.02.1997, Margrethe Mosbech, den 15.02.1997.
Indtrådt i bestyrelsen:
Direktør Juhani Paloluoma, den 15.02.1997.
Selskabet tegnes af to direktører i forening, eller af den samlede bestyrelse.
7 Feb 1997
Other
Vedtægter ændret:
18.11.1996.
15 Mar 1996
Other Audit change Address change People change
Vedtægter ændret:
18.12.1995.
Nyt navn:
M.B. PHARMOS ApS.
Ny adresse:
c/o Overlæge Johannes Mosbech, Høje Skodsborgvej 24, 2942 Skodsborg.
Show the full announcement
Ny kommune:
Søllerød.
Bestyrelse:
Indtrådt i bestyrelsen:
Konsulent Jesper Breuning-Hansen, den 18.12.1995, Klinikassistent Anette Breuning-Hansen, den 18.12.1995, Dr. med Johannes Fausbøll Mosbech, den 18.12.1995, Margrethe Mosbech, den 18.12.1995, Hans Ole Svendsen, den 18.12.1995.
Direktion:
Udtrådt af direktionen:
Per Emil Hasselbalch Stakemann, den 18.12.1995.
Indtrådt i direktionen:
Konsulent Jesper Breuning-Hansen, den 18.12.1995, Dr. med Johannes Fausbøll Mosbech, den 18.12.1995.
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør eller af en direktør alene, ligesom selskabet tegnes af den samlede bestyrelse.
Revision:
Udtrådt af revisionen:
Erik Tronborg Andersen, den 18.12.1995.
Indtrådt i revisionen:
REG.NR. A/S205073 REVISIONSFIRMAET S.A. CHRISTENSEN & W. KJÆRULFF, STATSAUTORISERET REVISIONSAKTIESELSKAB, St. Kongensgade 68, postboks 9015, 1264 København K.
23 Jan 1996
Other
Erhvervs- og Selskabsstyrelsen har modtaget vurderingsberetning i henhold til anparts- selskabslovens . 109, jfr. aktieselskabs- lovens . 6a for.
REG.NR. ApS223420 ApS KBUS 8 NR. 4186.
4 Oct 1995
New company
Stiftelsesdato:
01.09.1995.
Seneste vedtægtsdato:
01.09.1995.
Kapital:
kr. 200.000,00.
Show the full announcement
Indbetalingsmåde:
kontant kr. 200.000,00 til kurs 100,00.
Stifter:
REG.NR. ApS108426 VX 10.312 ApS, c/o Landsretssagfører Per Stakeman, Kronprinsessegade 18, 1306 København K.
Direktion:
Landsretssagfører Per Emil Hasselbalch Stakemann, den 01.09.1995.
Selskabet tegnes af en direktør.
Revision:
Statsaut. revisor Erik Tronborg Andersen, 4000 Roskilde.
Første regnskabsår:
01.09.1995 - 31.12.1996.
Regnskabsår:
01.01 - 31.12.

Registrations (registreringer)

Registration

Address: Ryvangs Allé 18
2100 København Ø
København Municipality
CVR record last changed: 11 Aug 2026
Data read: 14 Nov 2026

Production units

2 registered in CVR.

M.B. PHARMOS ApS
P-number 100601304224, 9999 Ukendt
M.B. PHARMOS A/S
P-number 1003642303Ryvangs Allé 18, 2100 København Ø

Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.

Ownership

People

Network

Financials

Changes

Registry facts

History (historik)

Registrations (registreringer)

Registration

Dandex in your own tools

Ownership

People

Financials

Who is behind it

Ownership

Dandex estimates

People

Current (0)

Founders (1)

Roles over time

Network

Headcount

Financials

Annual reports

Financials

Changes

Signals (signaler)

Changes

Pro for this company

Registry facts

Share capital

Mergers and demergers

Registry facts

History (historik)

Names (navne)

Addresses (adresser)

Statuses (virksomhedsstatus)

Audit firms (revision)

History (historik)

Registrations (registreringer)

Registrations (registreringer)

Registration

Production units

Dandex in your own tools

Who is behind it

Dandex estimates

Current (0)

Founders (1)

Roles over time

Headcount

Financials

Annual reports

Changes

Signals (signaler)

Pro for this company

Registry facts

Share capital

Mergers and demergers

History (historik)

Names (navne)

Addresses (adresser)

Statuses (virksomhedsstatus)

Audit firms (revision)

Registrations (registreringer)

Production units